Well, my friend Jenni has been sad lately and has had a lot of problems and so I came up with this magic cover song that is going to make all her woes melt like ice. If that doesn't work, I guess I can always buy her flowers and candy.
French’s®, the undisputed leader in mustard, announces two new mustard flavors and the newest introduction in the ketchup category. Crafted with only simple, quality ingredients, including stone-ground #1 grade mustard seed, French’s Classic Yellow Mustard has been America’s best-loved mustard for more than 100 years.
French’s continues its century-long dedication to producing only the highest quality products by introducing French’s Tomato Ketchup with no high-fructose corn syrup and two new mustard variations with exciting, on-trend flavors: French’s Sweet Yellow Mustard with a touch of brown sugar and French’s Spicy Yellow Mustard with cayenne pepper. Like French’s Classic Yellow Mustard, both new mustards are fat-free and gluten-free. French’s new ketchup and mustards are available now in stores nationwide.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7505551-frenchs-new-mustard-ketchup/
Four Seasons Hotels and Resorts, the world leader in luxury hospitality and service, unveils the new Four Seasons Private Jet – marking the establishment of a new standard in luxury hospitality experiences.
The culmination of a vision to deliver a fully immersive Four Seasons Private Jet Experience both in the air and on the ground, every element of the private jet journey has been re–imagined and designed through the Four Seasons lens to capture the company’s signature aesthetic, style and legendary service in the sky. Building on a history of innovation, the Four Seasons Private Jet exemplifies the company’s commitment to evolving the guest experience to anticipate and exceed the changing needs of the modern luxury traveller.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7506351-four-seasons-private-jet/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Today, Novo Nordisk announced a three-year extension of its Changing Diabetes® in Children programme. Since 2009, free insulin and access to diabetes care have been provided to more than 13,000 children in nine countries in Africa and South-East Asia. During the five years, 108 diabetes clinics have been established and 5,479 healthcare professionals have received diabetes care training.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7496851-novo-nordisk-children-with-diabetes/
Today, Novo Nordisk announced a three-year extension of its Changing Diabetes® in Children programme. Since 2009, free insulin and access to diabetes care have been provided to more than 13,000 children in nine countries in Africa and South-East Asia. During the five years, 108 diabetes clinics have been established and 5,479 healthcare professionals have received diabetes care training.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7496851-novo-nordisk-children-with-diabetes/
Today, Novo Nordisk announced a three-year extension of its Changing Diabetes® in Children programme. Since 2009, free insulin and access to diabetes care have been provided to more than 13,000 children in nine countries in Africa and South-East Asia. During the five years, 108 diabetes clinics have been established and 5,479 healthcare professionals have received diabetes care training.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7496851-novo-nordisk-children-with-diabetes/
Since ancient times, the egg has been regarded as a symbol of new life and has been associated with springtime celebrations, such as Easter and Passover. But, even during festive occasions, eggs can cause food poisoning (also called foodborne illness) if they are not handled properly. That’s why the U.S. Food and Drug Administration (FDA) reminds consumers to handle fresh eggs safely during their springtime celebrations and throughout the year.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7231951-u-s-fda-egg-safety/
International Integrated Solutions, Ltd. (IIS) today announced that it has been recognized with an HP PartnerOne Award for Americas Solution Partner of the Year for Big Data at the 2015 HP Global Partner Conference.
The HP PartnerOne Solution Partner of the Year Award honors IIS for its achievements in Big Data in the Americas. IIS has cultivated a robust offering of Big Data Solutions and Analytical Technologies allowing business leaders to deliver a more personalized, relevant customer experience. IIS fully leverages these technologies both through unsurpassed expertise and close relationships with valued partners.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7485351-iis-hp-partnerone-award-big-data/
Since the beginning of the year French Open champion Maria Sharapova has been competing for titles on the tennis tour. Before she left to start the new season, the Porsche brand ambassador did a few laps in a Porsche 911 Turbo S – and unveiled her formula for success.
Break of dawn in Los Angeles: The beach is still deserted at that time. Only Maria Sharapova is already on her feet, ready for her daily workout. Fitness is not the only key to her success. The tennis ace emphasizes mental strength. "As long as you put in all your power, your faith and your creativity, you can win every match", she says in a recent video for Porsche.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7446051-porsche-sharapova-key-success/
Significant advances toward cures for blood cancer patients, many of which were funded by The Leukemia & Lymphoma Society (LLS) over the past 65 years, are among the dramatic highlights featured in Ken Burns presents CANCER: THE EMPEROR OF ALL MALADIES, a film by Barak Goodman, to air on PBS stations nationwide from March 30-April 1. The documentary series is based on the Pulitzer Prize-winning book by Siddhartha Mukherjee, MD, The Emperor of All Maladies: A Biography of Cancer.
LLS has been a driving force behind treatment breakthroughs for patients with blood cancers, including leukemia, lymphoma and myeloma. As the world’s largest voluntary health agency dedicated to finding cures for blood cancer patients, LLS has invested more than $1billion in research to advance lifesaving treatments and cures.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7409151-lls-cancer-research-pbs-series/
